OBJECTIVE: Claudin-4 plays a key role in constructing the tight junction (TJ), and altered claudin-4 expression has been documented in various human malignancies; however, little is known about the biological significance of claudin-4 in colorectal cancers (CRCs). The aim of this study is to investigate the significance of claudin-4 expression in CRC and its association with clinicopathological factors. METHODS: The levels of claudin-4 expression in a total of 129 CRCs and 44 metastatic tumors were examined by immunohistochemistry. A small interfering RNA (siRNA)-mediated claudin-4 knockdown examination was also conducted to assess the biological role(s) of claudin-4 in cultured cells. RESULTS: Expression of claudin-4 at the intercellular membrane was well preserved at the surface of the tumor; however, decreased claudin-4 expression was detected in 57% of CRCs, particularly at the invasive front. Interestingly, decreased claudin-4 expression was detected in metastatic lesions of CRC. The siRNA-mediated claudin-4 knockdown in SW480 claudin-4-positive CRC cells upregulated cell motility, whereas no significant change was detected in cell proliferation. CONCLUSIONS: These observations suggested that disruption of claudin-4-mediated TJ construction enhances cancer cell invasion and metastasis in human CRC. Claudin-4 might be a good biomarker for diagnosing the risk of distant metastasis. Copyright (c) 2007 S. Karger AG, Basel.
OBJECTIVE:Claudin-4 plays a key role in constructing the tight junction (TJ), and altered claudin-4 expression has been documented in various humanmalignancies; however, little is known about the biological significance of claudin-4 in colorectal cancers (CRCs). The aim of this study is to investigate the significance of claudin-4 expression in CRC and its association with clinicopathological factors. METHODS: The levels of claudin-4 expression in a total of 129 CRCs and 44 metastatic tumors were examined by immunohistochemistry. A small interfering RNA (siRNA)-mediated claudin-4 knockdown examination was also conducted to assess the biological role(s) of claudin-4 in cultured cells. RESULTS: Expression of claudin-4 at the intercellular membrane was well preserved at the surface of the tumor; however, decreased claudin-4 expression was detected in 57% of CRCs, particularly at the invasive front. Interestingly, decreased claudin-4 expression was detected in metastatic lesions of CRC. The siRNA-mediated claudin-4 knockdown in SW480 claudin-4-positive CRC cells upregulated cell motility, whereas no significant change was detected in cell proliferation. CONCLUSIONS: These observations suggested that disruption of claudin-4-mediated TJ construction enhances cancer cell invasion and metastasis in human CRC. Claudin-4 might be a good biomarker for diagnosing the risk of distant metastasis. Copyright (c) 2007 S. Karger AG, Basel.
Authors: Paula Marincola Smith; Yash A Choksi; Nicholas O Markham; David N Hanna; Jinghuan Zi; Connie J Weaver; Jalal A Hamaamen; Keeli B Lewis; Jing Yang; Qi Liu; Izumi Kaji; Anna L Means; R Daniel Beauchamp Journal: Am J Physiol Gastrointest Liver Physiol Date: 2021-03-24 Impact factor: 4.052
Authors: Ágnes Holczbauer; Benedek Gyöngyösi; Gábor Lotz; Attila Szijártó; Péter Kupcsulik; Zsuzsa Schaff; András Kiss Journal: J Histochem Cytochem Date: 2013-02-05 Impact factor: 2.479
Authors: Kristin L M Boylan; Benjamin Misemer; Melissa S De Rycke; John D Andersen; Katherine M Harrington; Steve E Kalloger; C Blake Gilks; Stefan E Pambuccian; Amy P N Skubitz Journal: Int J Mol Sci Date: 2011-02-22 Impact factor: 5.923
Authors: Christian Melle; Günther Ernst; Bettina Schimmel; Annett Bleul; Ferdinand von Eggeling Journal: PLoS One Date: 2008-12-02 Impact factor: 3.240